A biotechnology company developing oral macrocyclic-peptide therapies designed to combine small-molecule convenience with ...

Israel’s Teva Pharmaceutical Industries has announced that the European Commission (EC) has granted marketing authorizations ...

Japanese drugmaker Otsuka has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for ...

UK pharma major GSK has announced that the National Institute for Health and Care Excellence (NICE) has issued final guidance ...

Meanwhile, Brazil’s Agência Nacional de Vigilância Sanitária has cracked down on unregistered GLP-1 “slimming pens”, France’s ...

Zetagen Therapeutics, a privately-held clinical-stage biotech pioneering first-of-its-kind, intratumoral treatments for ...

GV20 Therapeutics has reached a milestone in its collaboration with Japan’s Mitsubishi Tanabe Pharma (TSE: 4508), pushing ...

The UK medicines regulator has reiterated that routine childhood vaccines remain safe and essential, citing decades of ...

Samsung Life Science Fund has announced an equity investment in Phrontline Biopharma, a Chinese biotech advancing a new ...

The American medicines regulator strengthened its backing for precision oncology in 2024, issuing a record 63 review ...

Denmark’s Novo Nordisk saw its shares rise 4% to 298.50 kroner today, after it announced positive headline results from a ...

The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of children two years and older, teens and adults living with spinal muscular atrophy ...